Published on 21 October 2024 As of 21 October 2024, the Health Technology Assessment (HTA) Council hereby makes public its preliminary recommendations on the possible inclusion in the Philippine National Formulary (PNF) and thus the government financing of the following health technologies, for stakeholder feedback/comments: These health technologies were reviewed against national clinical practice guidelines continue reading : [FOR PUBLIC CONSULTATION] HTA Council Preliminary Recommendation on Dapivirine Vaginal Ring, Donepezil Hydrochloride, Tenofovir/Lamivudine/Dolutegravir and Tenofovir + Lamivudine in combination with Dolutegravir
HTA Council Preliminary Recommendation on Citicoline For Ischemic Stroke
Update as of 10 October 2024 : The public consultation and appeals period for the HTA Council Preliminary Recommendation on Citicoline for Ischemic Stroke ended on 09 October 2024. Having received no appeals, the HTA Division shall transmit the Final Recommendation to the Secretary of Health for Decision. Published 25 September 2024 As of 20 continue reading : HTA Council Preliminary Recommendation on Citicoline For Ischemic Stroke
HTA Council Preliminary Recommendation on Pneumococcal Conjugate Vaccines (PCV) for infants less than 1 year old and children aged 13 to 23 months for catch-up immunization
Update as of 10 October 2024 : The public consultation and appeals period for the HTA Council Preliminary Recommendation on Pneumococcal Conjugate Vaccines (PCV) for infants less than 1 year old and children aged 13 to 23 months for catch-up immunization ended on 09 October 2024. Published 25 September 2024 As of 20 September 2024, continue reading : HTA Council Preliminary Recommendation on Pneumococcal Conjugate Vaccines (PCV) for infants less than 1 year old and children aged 13 to 23 months for catch-up immunization